AAAAAA
Results:
1-11
|
Results: 11
Authors:
Shaldon, S
Citation: S. Shaldon, Dialysis membranes in convective treatments, NEPH DIAL T, 16(7), 2001, pp. 1509-1509
Authors:
Shaldon, S
Citation: S. Shaldon, Intravenous administration of iron in epoetin-treated haemodialysis patients, NEPH DIAL T, 16(5), 2001, pp. 1076-1077
Authors:
Shaldon, S
Citation: S. Shaldon, Bernard Charra honored with lifetime achievement award, DIALYSIS T, 30(10), 2001, pp. 624-624
Authors:
Shaldon, S
Citation: S. Shaldon, Can antihypertensive medications control BP in haemodialysis patients, NEPH DIAL T, 15(5), 2000, pp. 736-736
Authors:
Shaldon, S
Citation: S. Shaldon, How can survival of the well-dialyzed patient be increased?, SEMIN DIAL, 13(1), 2000, pp. 11-12
Authors:
Shaldon, S
Citation: S. Shaldon, Risks of vascular port access devices, SEMIN DIAL, 13(1), 2000, pp. 60-60
Authors:
Shaldon, S
Citation: S. Shaldon, A reply to Agarwal, CLIN NEPHR, 54(3), 2000, pp. 252-252
Authors:
Shaldon, S
Citation: S. Shaldon, Salt and hypertension in end-stage renal disease, BLOOD PURIF, 18(1), 2000, pp. 59-59
Authors:
Schaffer, J
Burchert, W
Floege, J
Gielow, P
Kionka, C
Linke, RP
Weiss, EH
Shaldon, S
Koch, KM
Citation: J. Schaffer et al., Recombinant versus natural human In-111-beta(2)-microglobulin for scintigraphic detection of A beta(2)m amyloid in dialysis patients, KIDNEY INT, 58(2), 2000, pp. 873-880
Authors:
Shaldon, S
Citation: S. Shaldon, Indwelling devices for vascular access in haemodialysis, NEPH DIAL T, 14(9), 1999, pp. 2258-2258
Authors:
Shaldon, S
Citation: S. Shaldon, Intravenous iron and anaemia in haemodialysis patients, NEPHRON, 80(4), 1998, pp. 485-485
Risultati:
1-11
|